Back
Direxion Dl Elctrc&Atnms vhcls Bull2XETF Vs. ProShares Ultra Nasdaq Biotechnology Industry Stock Comparison
Buy
58
EVAV
Direxion Dl Elctrc&Atnms vhcls Bull2XETF
Last Price:
18.33
Seasonality Move:
-20.25%
Sell
46
BIB
ProShares Ultra Nasdaq Biotechnology
Last Price:
58.90
Seasonality Move:
13.85%
Buy
58
Direxion Dl Elctrc&Atnms vhcls Bull2XETF (EVAV)
is a Buy
Is Direxion Dl Elctrc&Atnms vhcls Bull2XETF a Buy, Sell or Hold?
- The current Direxion Dl Elctrc&Atnms vhcls Bull2XETF [EVAV] share price is $19.93. The Score for EVAV is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
- EVAV is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
46
ProShares Ultra Nasdaq Biotechnology (BIB)
is a Sell
Is ProShares Ultra Nasdaq Biotechnology a Buy, Sell or Hold?
- The current ProShares Ultra Nasdaq Biotechnology [BIB] share price is $61.75. The Score for BIB is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
- BIB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
EVAV Stock Price Chart
What is Direxion Dl Elctrc&Atnms vhcls Bull2XETF's stock price today?
-
The Direxion Dl Elctrc&Atnms vhcls Bull2XETF share price today is $19.93
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EVAV is experiencing selling pressure, which indicates risk of future bearish movement.
BIB Stock Price Chart
What is ProShares Ultra Nasdaq Biotechnology's stock price today?
-
The ProShares Ultra Nasdaq Biotechnology share price today is $61.75
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BIB is experiencing selling pressure, which indicates risk of future bearish movement.
EVAV Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.21 | Buy |
| Relative Strength Index (14 RSI): | 52.34 | Buy |
| Chaikin Money Flow: | -5688 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (18.09 - 20.43) | Buy |
| Bollinger Bands (100): | (15.57 - 20.71) | Buy |
BIB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.12 | Buy |
| Relative Strength Index (14 RSI): | 43.98 | Sell |
| Chaikin Money Flow: | -16544 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (61.68 - 65.1) | Sell |
| Bollinger Bands (100): | (61.18 - 66.64) | Sell |
EVAV Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 19.49 | Buy |
| 20-day SMA: | 19.12 | Buy |
| 50-day SMA: | 19 | Buy |
| 200-day SMA: | 19.52 | Buy |
| 8-day EMA: | 19.73 | Buy |
| 20-day EMA: | 19.46 | Buy |
| 50-day EMA: | 18.99 | Buy |
| 200-day EMA: | 23.87 | Sell |
BIB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 64.13 | Sell |
| 20-day SMA: | 63.27 | Sell |
| 50-day SMA: | 63.75 | Sell |
| 200-day SMA: | 59.99 | Buy |
| 8-day EMA: | 63.69 | Sell |
| 20-day EMA: | 63.49 | Sell |
| 50-day EMA: | 63.53 | Sell |
| 200-day EMA: | 60.5 | Buy |
Direxion Dl Elctrc&Atnms vhcls Bull2XETF Earnings Growth & EVAV Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
ProShares Ultra Nasdaq Biotechnology Earnings Growth & BIB Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Direxion Dl Elctrc&Atnms vhcls Bull2XETF Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
ProShares Ultra Nasdaq Biotechnology Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||